Daily thymosin alpha-1 injections increased immune cells, reduced tumor weight, and prevented organ metastasis in tumor-bearing mice in a dose-dependent manner.
Reduced tumor + metastasis7 days of thymosin alpha-1 both reduced primary tumor weight and prevented cancer spread to other organs in mice
What the researchers found
Thymosin alpha-1 (0.01-10 μg SC daily for 7 days) increased thymocytes and blood cells, reduced primary tumor weight, and inhibited organ colonization by metastatic cells in tumor-bearing BALB/c mice.
Why it matters
Thymosin alpha-1 is already used clinically as an immune enhancer. Demonstrating anti-tumor and anti-metastatic activity strengthens the case for its use as a cancer immunotherapy adjuvant.
How the study worked
Animal study in BALB/c mice bearing tumors. Thymosin alpha-1 administered SC daily for 7 consecutive days at multiple doses. Immune cell counts, tumor weight, and metastatic organ colonization assessed.
What this study cannot tell us
Mouse model with specific tumor type. Short 7-day treatment. Human cancer is more complex than murine models. The specific immune mechanisms driving tumor reduction were not fully characterized.
How to read the evidence
Preliminary animal evidence with clear dose-dependent effects on immune cells, tumor weight, and metastasis.
When this study was published
Published in 2000. Thymosin alpha-1 has continued to be studied as a cancer immunotherapy adjuvant, with clinical trials in various cancers.
The bigger picture
Cancer immunotherapy aims to boost the immune system to fight tumors. Thymosin alpha-1's ability to simultaneously enhance immune cells and reduce tumor growth and spread aligns perfectly with this therapeutic strategy.
Questions still open
- Which immune cell populations are responsible for the anti-tumor effect?
- Does thymosin alpha-1 enhance responses to conventional chemotherapy?
- What is the optimal dosing schedule for anti-cancer effects?
Common questions
Can thymosin alpha-1 fight cancer?
How does it work against cancer?
Read the original research
Thymosin alpha(1) application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice.
Cancer letters, 159(1), 9-13
Citation
Beuth, J; Schierholz, J M; Mayer, G. (2000). Thymosin alpha(1) application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice.. Cancer letters, 159(1), 9-13.